ST6GAL1 and breast cancer: Hence, dynamic changes in both individual and clustered CTCs impact overall tumor survival rates, and the ST6GAL1 glycoprotein substrate PODXL may be a favorable candidate target against BC-related micrometastases.241 The presence of ctDNA also holds significant prognostic value in distant metastatic recurrence of various tumors.